{
    "type": "ETC",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": false,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "Leverage",
        "Synthetic Replication",
        "Swap Usage",
        "Daily Reset Mechanism"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Gold 2x Daily Leveraged ETC is classified as complex under MiFID II due to several key factors: 1) It uses synthetic replication via swaps to achieve its 2x daily leveraged exposure to gold, 2) The product employs a daily reset mechanism which can lead to significant compounding effects and deviations from expected returns over time, 3) The KIID explicitly states this is not a simple product and may be difficult to understand, 4) The PRIIPs KID includes a comprehension warning, 5) The product is structured as a debt security with counterparty risk exposure, 6) The risk rating is 7/7 (highest level), and 7) The recommended holding period is only 1 day, indicating high volatility and complexity. While the product is fully collateralized, the use of leverage, synthetic replication, and the daily compounding effect all contribute to its complex nature. The fact that it's not UCITS compliant and is structured as an ETC rather than a traditional ETF further supports this classification.",
    "confidence": 95,
    "counter_argument": "One might argue that the product is fully collateralized and the leverage is capped at 2x, making it less complex than other leveraged products. However, the daily reset mechanism and the need for continuous monitoring override this argument, as these features require sophisticated understanding beyond typical retail investor knowledge.",
    "risk_level_assessment": "The product's risk profile is extremely high (7/7), which aligns with its complex classification. The leveraged nature, daily compounding, and potential for significant deviations from expected returns all contribute to this high-risk assessment. The product is explicitly stated to be suitable only for informed investors who understand the risks of leveraged products and intend to monitor them daily."
}